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Abstract Among the diverse presentations of neurobru-
cellosis, solitary intracranial mass lesions are extremely
rare. To the best of our knowledge, we describe here the
second case of neurobrucellosis mimicking a cerebral
tumor caused by Brucella melitensis. The mass lesion was
clinically and radiologically indistinguishable from a brain
tumor. The diagnosis was established by isolating Brucella
melitensis in a blood culture and a positive Wright’s
agglutination test on the cerebrospinal ﬂuid at 1:320 titers.
Parafﬁn sections of the cerebral mass showed nongranul-
omatous encephalitis. We suggest that patients with an
isolated intraparenchymal mass lesion with nongranulo-
matous encephalitis should also be studied for brucellosis
in endemic areas.
Keywords Neurobrucellosis  Nongranulomatous
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Introduction
Brucellosis is a zoonotic disease caused by intracellular
gram-negative bacteria of the Brucella genus. It is endemic
in many countries, including Turkey [1–3]. Brucella mel-
itensis is known to be the most common etiological agent
of human brucellosis in Turkey [4]. Neurobrucellosis is a
rare, severe form of systemic infection with a broad range
of clinical syndromes [3]. The broad spectrum of clinical
involvement and nonspeciﬁc signs and symptoms may
interfere with an early diagnosis of this disease [1]. Among
its varied presentations, solitary intracranial masses are
very uncommon in adults [1, 3]. We present a rare case of
neurobrucellosis with an isolated brain mass, mimicking a
cerebral tumor in which the speciﬁc diagnosis was made
via bacterial isolation in the blood and seroagglutination in
the cerebrospinal ﬂuid (CSF).
Case report
A 20-year-old woman presented with left arm and leg
numbness and weakness for 1 month. One week before
admission, the symptoms had become particularly severe;
they had been accompanied by a mild headache. The
patient had a history of previous brucellosis. The diagnosis
of brucellosis was ﬁrst made 4 months previously. At that
time, she was treated with rifampicin 600 mg/day and
doxycycline 200 mg/day for 45 days. She had remained
free of symptoms until 1 month previously.
Upon examination, the patient was afebrile, and neuro-
logical examination showed left hemiparesis. Routine
M. Erdem  M. Namiduru (&)  I. Karaoglan  V. B. Kecik
Department of Infectious Diseases, Faculty of Medicine,
University of Gaziantep, Gaziantep, Turkey
e-mail: mustafanamiduru@gmail.com
M. Erdem
e-mail: yesimcan_1978@hotmail.com
I. Karaoglan
e-mail: ilkaykaraoglan10@hotmail.com
V. B. Kecik
e-mail: vbosnak@hotmail.com
A. Aydin
Department of Pathology, Faculty of Medicine,
University of Gaziantep, Gaziantep, Turkey
e-mail: aydin@gantep.edu.tr
M. Tanriverdi
Clinic of Infectious Disease, Suruc State Hospital,
Sanliurfa, Turkey
e-mail: tanriverdi@gantep.edu.tr
123
J Infect Chemother (2012) 18:767–770
DOI 10.1007/s10156-011-0365-4
Open access under the Elsevier OA license. .
laboratory analyses indicated only leukocytosis (19,500/
mm3). The differential blood count indicated 85.6% neu-
trophils and 4.8% lymphocytes. The C-reactive protein
(CRP) value (40 mg/dl) and sedimentation rate (38 mm/h)
were elevated. An initial serological titer for Brucella was
positive at 1:640 via Wright’s agglutination test. Then,
blood cultures were sent for Brucella. Magnetic resonance
imaging (MRI) showed a 1.5 9 1.5 cm enhancing nodular
lesion with moderate surrounding edema in the right pari-
etal lobe (Fig. 1). These ﬁndings suggested a cerebral
tumor. The patient underwent a right parietal craniotomy
with the total excision of the neoplasm. The ﬁnal exam-
ination of the pathological specimens showed a non-
granulomatous encephalitis that consisted of diffuse
lymphocytic inﬁltrates and perivascular lymphocytic cuff-
ing (Fig. 2). The stains for mycobacteria, bacteria, fungi,
and spirochetes were negative. These observations led us to
investigate the etiology of encephalitis. Then, a lumbar
puncture was performed. Examination of the CSF showed
no pleocytosis, a protein concentration of 48 mg/dl, and a
glucose level of 52 mg/dl. CSF samples were sent for
Gram and Ziehl-Neelsen staining and bacterial, mycobac-
terial, and fungal cultures. Polymerase chain reaction
(PCR) testing for Mycobacterium tuberculosis was per-
formed as well. All results, as well as those of the CSF
serologies for cytomegalovirus (CMV), Epstein–Barr virus
(EBV), herpes simplex virus type 1 and 2 (HSV-1 and
HSV-2), rubella, and toxoplasmosis, were negative. Serum
serologies for human immunodeﬁciency virus, serum
hepatitis C, CMV, EBV, HSV-1 and HSV-2, rubella, Bor-
relia burgdorferi, toxoplasmosis, and syphilis, except for
serum hepatitis B, were negative.Wright’s agglutination test
in the CSF was positive at 1:320 titers. Eventually, Brucella
melitensis was isolated in the blood culture. Based on these
ﬁndings, the patient was diagnosed with neurobrucellosis,
presenting as nongranulomatous encephalitis. Therapy with
rifampin (600 mg/day), trimethoprim–sulfamethoxazole
(640–3,200 mg/day), and ceftriaxone (2 g/day) was started
and continued for 3 weeks. Thereafter, therapy with rifam-
pin (600 mg/day) and trimethoprim–sulfamethoxazole
(640–3,200 mg/day) was maintained, but ceftriaxone was
replaced with doxycycline (200 mg/day), and the new
antimicrobial combination was planned to be continued
for 6 months. On hospital day 14, the patient’s symptoms
had apparently subsided. During the next 6 months, the
patient will be followed up closely with serological,
microbiological, and MRI imaging assays until complete
recovery.
Discussion
Brucellosis is still a signiﬁcant health problem in many
parts of the world, especially in the Mediterranean and
Middle East regions [5]. Its incidence is increasing in
Turkey [6]. Brucella melitensis infection is endemic in
certain areas of Turkey, such as the eastern and south-
eastern Anatolia regions [2]. Our case also had an etio-
logical agent of infection, called B. melitensis, and said
patient had lived in the southeastern Anatolia region of
Turkey.
Central nervous system (CNS) involvement in brucel-
losis or neurobrucellosis is rare [5]. Because of its non-
speciﬁc manifestations and broad spectrum of clinical
syndromes, neurobrucellosis may occasionally be over-
looked [1]. Brucella exhibits a great afﬁnity for the
meninges [5]. Therefore, the most frequent clinical syn-
dromes associated with neurobrucellosis are meningitis or
meningoencephalitis. Mass lesions in the brain are extre-
mely uncommon and can be documented radiologically
and pathologically [3]. In the present study, we encoun-
tered Brucella encephalitis, presenting as a solitary brain
mass, mimicking a cerebral tumor, but there was no men-
ingeal inﬂammation. To date, neurobrucellosis with a sol-
itary intracranial mass mimicking a cerebral tumor has
been documented in only two adult patients [1, 3]. In only
Fig. 1 a Axial T1-weighted
gadolinium-enhanced image
shows a strongly enhancing
1.5 9 1.5 cm nodule in the right
parietal cortex surrounded by
vasogenic edema. b Axial T2-
weighted image demonstrates
vasogenic edema surrounding a
low-signal central nodule
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one of these cases was the deﬁnitive diagnosis of neuro-
brucellosis made via bacterial isolation; Brucella melitensis
was cultured in postoperative brain tissue specimens [3].
Our patient is the second case of neurobrucellosis to be
misdiagnosed as a brain tumor before the identiﬁcation
of encephalitis caused by Brucella melitensis. We isolated
B. melitensis in the blood culture in our case.
The differential diagnosis of a mass-occupying lesion
with enhancement after the administration of a contrast
agent is a brain tumor or abscesses [7]. In our patient, MRI
imaging revealed an enhanced lesion with vasogenic edema
in the right parietal lobe, interpreted as a cerebral tumor.
In this case, the diagnosis of nongranulomatous
encephalitis was made after a neurosurgical cerebral
biopsy. The other adult patients with neurobrucellosis
mimicking a brain tumor showed the histopathological
ﬁndings of marked granulomatous encephalitis in previous
studies [1, 3]. Nongranulomatous encephalitis was reported
only in a child with focal cerebral involvement from neu-
robrucellosis [5].
Despite optimal antimicrobial treatment, brucellosis
presents as an infectious disease with a tendency to pro-
gress to a chronic state, accompanied by relapses. As per
pathogenesis of neurobrucellosis, because of direct inva-
sion of bacteria through the CNS during the acute bacterial
period or the capability of Brucella bacteria to survive for
prolonged durations in phagocytes, it may develop after a
long time following a disturbance in host immunity.
Noncompliance to treatment is another important factor
that increases the risk of chronicity [8, 9].
Viruses are the most common cause of acute or subacute
encephalitis. The other potentially treatable conditions that
may mimic viral encephalitis are abscesses, subdural
empyema (bacterial, listerial, fungal, mycoplasmal),
tuberculosis, toxoplasmosis, tumor, systemic lupus ery-
thematosus, toxic encephalopathy, vascular disease, fungal
infections (mucormycosis), Rickettsia, and Cryptococcus
[10]. Remarkably, here, we also observed neurobrucellosis
as another condition, mimicking viral encephalitis.
The speciﬁc diagnosis of neurobrucellosis is based on
seroagglutination (positive Wright’s agglutination or Coo-
mbs’ test at C1:160 titers) in the CSF and blood and CSF
cultures (positive in\15% of the cases), which have rel-
atively low sensitivities [11]. Because isolation of the
organism in the CSF and serum is rarely possible, the
diagnosis is usually made by seroagglutination in the CSF.
Positive blood culture is crucial as a deﬁnitive diagnostic
tool. Furthermore, the culture of surgical or biopsy speci-
mens may reveal a localized infection caused by Brucella
species, such as neurobrucellosis [3, 12].
Brucellosis requires high suspicion to dismiss the diag-
nosis in endemic areas [13]. In our case, the deﬁnitive
diagnosis of neurobrucellosis was established by isolating
Brucella melitensis in the blood culture and a positive
Wright’s agglutination test in the CSF at 1:320 titers.
Brucella-related cerebral masses can be treated medi-
cally, reducing the potential long-term neurological com-
plications of resection [3]. In our case, we unexpectedly
found neurobrucellosis as the cause of a solitary intracra-
nial mass lesion. Therefore, our patient underwent a mass
resection before medical therapy.
In conclusion, despite its rareness, it is crucial that
neurobrucellosis be considered in the context of a solitary
intracranial mass lesion in the differential diagnosis of
cerebral tumors, particularly in endemic areas. Hence,
Fig. 2 Nongranulomatous encephalitis. a Hematoxylin and eosin
(H&E)-stained brain section shows scattered lymphocytic inﬁltrates
and perivascular lymphocytic cufﬁng. b Brain section stained for
leukocyte common antigen demonstrates perivascular lymphocytic
cufﬁng
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patients having these lesions, with either granulomatous or
nongranulomatous encephalitis, should be studied for
Brucella with blood and CSF cultures and serological tests
in the serum and CSF.
References
1. Miguel PS, Ferna´ndez G, Vasallo FJ, Hortas M, Lorenzo JR,
Rodrı´guez I, et al. Neurobrucellosis mimicking cerebral tumor:
case report and literature review. Clin Neurol Neurosurg. 2006;
108:404–6.
2. Akdeniz H, Irmak H, Anlar O, Demiroz AP. Central nervous
system brucellosis: presentation, diagnosis and treatment.
J Infect. 1998;36:297–301.
3. Sohn AH, Probert WS, Glaser CA, Gupta N, Bollen AW, Wong
JD, et al. Human neurobrucellosis with intracerebral granuloma
caused by a marine mammal Brucella spp. Emerg Infect Dis.
2003;9:485–8.
4. Refai M. Incidence and control of brucellosis in the Near East
region. Vet Microbiol. 2002;90:81–110.
5. Martı´nez-Chamorro E, Mun´oz A, Esparza J, Mun´oz MJ, Gian-
gaspro E. Focal cerebral involvement by neurobrucellosis: path-
ological and MRI ﬁndings. Eur J Radiol. 2002;43:28–30.
6. Sengoz Inan A, Ceran N, Erdem I, Engin DO, Senbayrak S,
Ozyurek SC. Neurobrucellosis with transient ischemic attack,
vasculopathic changes, intracerebral granulomas and basal gan-
glia infarction: case report. J Med Case Rep. 2010;340:1–5.
7. Siddiqui AA, Bashir SH, Ali Shah A, Sajjad Z, Ahmed N,
Jooma R, et al. Diagnostic MRI imaging feature of craniocerebral
aspergillosis of sino-nasal origin in immunocompetent patients.
Acta Neurochir. 2006;148:155–66.
8. al Deep SM, Yaqub BA, Sharif HS, Phadke JK. Neurobrucellosis:
clinical characteristics, diagnosis and outcome. Neurology.
1989;39:498–501.
9. Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mausa AR, Saadah
MA. Clinical catagories of neurobrucellosis: a report 19 cases.
Brain. 1987;110:213–23.
10. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections
and emerging pathogens. Lancet. 2002;359:507–14.
11. Young FJ. Brucella species. In: Mandel GL, Bennett JE, Dolin R,
editors. Principles and practice of infectious diseases, 6th edn.
Philadelphia: Churchill Livingstone; 2005. p. 2669–74.
12. Daglioglu E, Bayazit N, Okay O, Dalgic A, Hatipoglu HG,
Ergungor F. Lumbar epidural abscess caused by Brucella species:
report of two cases. Neurocirugia. 2009;20:159–62.
13. Pina MA, Modrego PJ, Uroz JJ, Cobeta JC, Lerin FJ, Baiges JJ.
Brucellar spinal epidural abscess of cervical location: report of
four cases. Eur Neurol. 2001;45:249–53.
770 J Infect Chemother (2012) 18:767–770
123
